ADRB2 and ovarian carcinoma: For instance, Adrβ2 signals have shown to activate the survival phosphatase, DUSP1, which in turn dephosphorylates JNK and c-jun to promote ovarian cancer cell survival pre-treated with cisplatin or paclitaxel (24).